FKBP1AP2

Across TCGA pan-cancer cohorts, FKBP1AP2 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of FKBP1AP2’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where FKBP1AP2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types FKBP1AP2 is over-expressed in tumor, although a few such as STAD show the opposite, repressed pattern.

BRCA and STAD are the cancer types where FKBP1AP2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in FKBP1AP2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	All	+0.089	.043	2	view →
STAD	Female	III,IV	−0.410	.005	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

FKBP1AP2–BRCA

Open the BRCA breakdown →